Ubiquitin-specific peptidase 22 functions and its involvement in disease

Johanna Melo-Cardenas, Yusi Zhang, Donna Zhang, Deyu Fang

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Deubiquitylases remove ubiquitin moieties from different substrates to regulate protein activity and cell homeostasis. Since this posttranslational modification plays a role in several different cellular functions, its deregulation has been associated with different pathologies. Aberrant expression of the Ubiquitin-Specific Peptidase 22 (USP22) has been associated with poor cancer prognosis and neurological disorders. However, little is known about USP22 role in these pathologies or in normal physiology. This review summarizes the current knowledge about USP22 function from yeast to human and provides an overview of the possible mechanisms by which USP22 is emerging as a potential oncogene.

Original languageEnglish (US)
Pages (from-to)44848-44856
Number of pages9
JournalOncotarget
Volume7
Issue number28
DOIs
StatePublished - 2016

Fingerprint

Ubiquitin
Peptide Hydrolases
Pathology
Post Translational Protein Processing
Nervous System Diseases
Oncogenes
Homeostasis
Yeasts
Neoplasms
Proteins

Keywords

  • Ataxia
  • Cancer
  • Deubiquitylation
  • Oncogene
  • USP22

ASJC Scopus subject areas

  • Oncology

Cite this

Ubiquitin-specific peptidase 22 functions and its involvement in disease. / Melo-Cardenas, Johanna; Zhang, Yusi; Zhang, Donna; Fang, Deyu.

In: Oncotarget, Vol. 7, No. 28, 2016, p. 44848-44856.

Research output: Contribution to journalArticle

Melo-Cardenas, Johanna ; Zhang, Yusi ; Zhang, Donna ; Fang, Deyu. / Ubiquitin-specific peptidase 22 functions and its involvement in disease. In: Oncotarget. 2016 ; Vol. 7, No. 28. pp. 44848-44856.
@article{8919dae0403543c38ccaf3ceae0b9e45,
title = "Ubiquitin-specific peptidase 22 functions and its involvement in disease",
abstract = "Deubiquitylases remove ubiquitin moieties from different substrates to regulate protein activity and cell homeostasis. Since this posttranslational modification plays a role in several different cellular functions, its deregulation has been associated with different pathologies. Aberrant expression of the Ubiquitin-Specific Peptidase 22 (USP22) has been associated with poor cancer prognosis and neurological disorders. However, little is known about USP22 role in these pathologies or in normal physiology. This review summarizes the current knowledge about USP22 function from yeast to human and provides an overview of the possible mechanisms by which USP22 is emerging as a potential oncogene.",
keywords = "Ataxia, Cancer, Deubiquitylation, Oncogene, USP22",
author = "Johanna Melo-Cardenas and Yusi Zhang and Donna Zhang and Deyu Fang",
year = "2016",
doi = "10.18632/oncotarget.8602",
language = "English (US)",
volume = "7",
pages = "44848--44856",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "28",

}

TY - JOUR

T1 - Ubiquitin-specific peptidase 22 functions and its involvement in disease

AU - Melo-Cardenas, Johanna

AU - Zhang, Yusi

AU - Zhang, Donna

AU - Fang, Deyu

PY - 2016

Y1 - 2016

N2 - Deubiquitylases remove ubiquitin moieties from different substrates to regulate protein activity and cell homeostasis. Since this posttranslational modification plays a role in several different cellular functions, its deregulation has been associated with different pathologies. Aberrant expression of the Ubiquitin-Specific Peptidase 22 (USP22) has been associated with poor cancer prognosis and neurological disorders. However, little is known about USP22 role in these pathologies or in normal physiology. This review summarizes the current knowledge about USP22 function from yeast to human and provides an overview of the possible mechanisms by which USP22 is emerging as a potential oncogene.

AB - Deubiquitylases remove ubiquitin moieties from different substrates to regulate protein activity and cell homeostasis. Since this posttranslational modification plays a role in several different cellular functions, its deregulation has been associated with different pathologies. Aberrant expression of the Ubiquitin-Specific Peptidase 22 (USP22) has been associated with poor cancer prognosis and neurological disorders. However, little is known about USP22 role in these pathologies or in normal physiology. This review summarizes the current knowledge about USP22 function from yeast to human and provides an overview of the possible mechanisms by which USP22 is emerging as a potential oncogene.

KW - Ataxia

KW - Cancer

KW - Deubiquitylation

KW - Oncogene

KW - USP22

UR - http://www.scopus.com/inward/record.url?scp=84978730188&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978730188&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.8602

DO - 10.18632/oncotarget.8602

M3 - Article

C2 - 27057639

AN - SCOPUS:84978730188

VL - 7

SP - 44848

EP - 44856

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 28

ER -